Welcome & Opening Remarks

2.00 PM
Thought Leadership Interview: Advancing Immuno-Oncology – Bridging Into Biomarkers, Therapy, and Translation

Presented by Sophia N. Karagiannis, Professor of Translational Cancer Immunology and Immunotherapy, St John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London

2.20 – 2:50 PM
Panel Discussion:  Advancing Immuno-Oncology: Biomarkers and Next-Generation Therapeutic Strategies
Moderated by David Krige, Chief Development Officer, Accession Therapeutics

Panellists:

Lilly Wollman, CEO, Synteny AI

Sophia N. Karagiannis, Professor of Translational Cancer Immunology and Immunotherapy, St John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London King’s College London

Vaios Karanikas, Translational Biomarker Sciences Group Head, Expert Biomarker Experimental Medicine Leader, Early Development Oncology, Roche Pharma Research and Early Development (pRED), Roche Innovation Center Zurich

30 minute panel discussion

This webinar will explore the key bioanalytical challenges associated with complex biologics and advanced therapeutic platforms. The discussion will focus on bioanalysis of complex biologics, translational challenges, analytical and regulatory considerations, and strategies for successfully advancing programs from bench to clinic.

Our expert panel will examine analytical characterization, method development, and regulatory expectations in preclinical studies, providing practical insights into navigating scientific and strategic hurdles across the development pathway.

Key Topics:

• Bioanalysis of complex biologics in preclinical studies
• Characterization and translational challenges
• Analytical and regulatory considerations
• From bench to clinic: bioanalytical strategies and hurdles
• Regulatory considerations in preclinical studies.

Moderator: Kelly Loyet, Distinguished Scientist and Director, Biochemical and Cellular Pharmacology, Research, Genentech

Panellist:

• Thomas Kraft, Subchapter Lead, ADME; Senior Principal Scientist, Roche Diagnostics GmbH
• Alessandro Gori, Lead Researcher, CNR (Consiglio Nazionale delle Ricerche)
• Julia Deuel, Director CMC, Voisin Consulting Life Sciences